About: http://webisa.webdatacommons.org/366774442

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	In 2009, pralatrexate was approved by the FDA for treatment of relapsed or refractory peripheral T cell lymphoma, a form of lymphoma for which no approved therapeutic options existed previously.
http://www.w3.org/ns/prov#wasQuotedFrom	mskcc.org